Showing results (31-40 of 239) with videos related to
Sort By:
Pageof 24
Seminars in Dialysis|March 5, 2002
Quality outcomes and obstacles to their achievement in end-stage renal diseaseSteven Fishbane, Richard GoldmanThe Journal of Family Practice|August 12, 2022
Improving Detection and Management of Anemia in CKDSteven Fishbane, Stephen BruntonSeminars in Dialysis|April 21, 2012
The new label for erythropoiesis stimulating agents: the FDA'S sentenceSteven Fishbane, Kenar D JhaveriAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 14, 2015
The emerging role of biosimilar epoetins in nephrology in the United StatesSteven Fishbane, Hitesh H ShahNephron. Clinical Practice|June 29, 2007
Implications of neocytolysis for optimal management of anaemia in chronic kidney diseaseClarence P Alfrey, Steven FishbaneKidney International. Supplement|July 31, 2010
Anemia management in chronic kidney diseaseSteven Fishbane, Allen R NissensonHemodialysis International. International Symposium on Home Hemodialysis|April 4, 2017
Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysisSteven Fishbane, Hitesh H ShahKidney International|August 18, 2005
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietinSteven Fishbane, Jeffrey S BernsKidney International|June 30, 2012
A physician's perseverance uncovers problems in a key nephrology studySteven Fishbane, Jay B WishAdvances in Chronic Kidney Disease|September 4, 2019
Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney DiseaseHitesh H Shah, Steven FishbanePageof 24